Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle-Reference-Cited by-同舟云学术

Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle

Published:2006-09 Issue:6 Volume:61 Page:1543-1555
ISSN:0950-382X
Container-title:Molecular Microbiology
language:en
Short-container-title:Mol Microbiol

Author:

Wolf K.,Betts H. J.,Chellas-Gery B.,Hower S.,Linton C. N.,Fields K. A.

Publisher

Wiley

Subject

Molecular Biology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2958.2006.05347.x/fullpdf

Reference51 articles.

1. Genomic transcriptional profiling of the developmental cycle ofChlamydia trachomatis

2. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis

3. Chlamydia trachomatis utilizes the host cell microtubule network during early events of infection

4. From The Cover: A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin

5. Temporal Analysis of Coxiella burnetii Morphological Differentiation

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type III Secretion in Chlamydia;Microbiology and Molecular Biology Reviews;2023-09-26

2. Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems;Frontiers in Cellular and Infection Microbiology;2023-01-10

3. Alternative strategies for Chlamydia treatment: Promising non-antibiotic approaches;Frontiers in Microbiology;2022-11-23

4. Crystal structures of WrbA, a spurious target of the salicylidene acylhydrazide inhibitors of type III secretion in Gram-negative pathogens, and verification of improved specificity of next-generation compounds;Microbiology;2022-07-13

5. Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli;Antimicrobial Agents and Chemotherapy;2021-11-17